Lv3
400 积分 2024-12-09 加入
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials
17小时前
待确认
Assessment of Visual Function with Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa in the Randomized XIRIUS Phase 2/3 Study
3天前
已完结
RPGR Transcription Studies in Mouse and Human Tissues Reveal a Retina-Specific Isoform That Is Disrupted in a Patient With X-Linked Retinitis Pigmentosa
3个月前
已完结
Prevalence of RPGR-mutated X-linked retinitis pigmentosa among males
3个月前
已完结
Hyperthyroidism: aetiology, pathogenesis, diagnosis, management, complications, and prognosis
4个月前
已完结
Immune responses to retinal gene therapy using adeno-associated viral vectors – Implications for treatment success and safety
4个月前
已完结
Standardizatlon of Vitreal inflammatory Activity in Intermediate and Posterior Uveitis
5个月前
已完结
Clinical Perspectives and Trends: Microperimetry as a Trial Endpoint in Retinal Disease
5个月前
已关闭
Novel Mutations of RPGR in Chinese Retinitis Pigmentosa Patients and the Genotype-Phenotype Correlation
5个月前
已完结
皖公网安备34019202002308
